Dysbiosis, or an imbalance in gut microbiota, is associated with metabolic diseases, especially T2DM, and can cause changes in the signaling pathways of intestinal hormone secretion, leading to various health problems [156]
The Medicare GLP-1 Bridge is a temporary demonstration run by the Centers for Medicare and Medicaid Services (CMS) that gives eligible Part D members access to certain GLP-1 weight-loss drugs for $50 a month
Dehydration raises nausea risk and can cause other issues, so make fluids a priority
Hypoglycemia risk : Lower risk than with insulin, but non-trivial if combined with other glucose-lowering medications
The presence of thyroid peroxidase (TPO) antibodies or thyroglobulin antibodies supports an autoimmune aetiology but is not essential for diagnosis
Additionally, all participants in the highest-dose group achieved at least 5% weight loss, with 26% of participants losing 30% or more of their baseline weight [R]